Filter Results:
(130)
Show Results For
- All HBS Web
(130)
- People (1)
- News (57)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
Show Results For
- All HBS Web
(130)
- People (1)
- News (57)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
- Web
Organizational Behavior - Faculty & Research
2025. Radical Transformation at Bayer: Dynamic Shared Ownership By: Boris Groysberg and Gamze Yucaoglu April 2025 | Case | Faculty Research In 2023, Bill Anderson became CEO of Bayer AG, a 160-year-old life sciences giant looking to strengthen its View Details
- 19 Sep 2023
- Research & Ideas
What Chandrayaan-3 Says About India's Entrepreneurial Approach to Space
appeared in the Harvard Gazette. Interview has been edited for clarity and length. You Might Also Like: 5 Qualities That Help Companies Thrive for Decades—Even Centuries When Experts Play It Too Safe: Innovation Lessons from a NASA Experiment Could a Business Model... View Details
- 15 Nov 2022
- Book
Stop Ignoring Bad Behavior: 6 Tips for Better Ethics at Work
In 1995, Purdue Pharma began selling a powerful and addictive opioid drug called OxyContin. The company was aware that the drug, which was marketed to doctors as a safe way to manage chronic pain, was a potent narcotic that could quickly... View Details
Keywords: by Pamela Reynolds
- 30 May 2024
- Research & Ideas
Racial Bias Might Be Infecting Patient Portals. Can AI Help?
differences in response to different types of customers,” Stern says. “To the extent those exist, that means you’re not serving a certain group of customers, and you’re potentially leaving money on the table.” You Might Also Like: The FDA’s Speedy Drug Approvals Are... View Details
- 01 Jun 2023
- News
Bridging the ESG Data Gap
Megan Murday The idea for a digital platform to help venture capitalists calculate, benchmark, and improve portfolio ESG performance crystallized while Megan Murday (MBA 2021) was studying at HBS. Now the CEO of the software startup Metric, she says that “investors... View Details
Keywords: Deborah Blagg
- 01 Jun 2024
- News
Quantum Leap
pharmaceutical and chemical industries have taken note: The venture capital arm of the pharma giant Merck, for instance, invested $5 million in SEEQC’s Series A round, where it was joined by the South Korean chemical company LG Chem,... View Details
- Web
Fast Facts - Health Care
Health Care Initiative Fast Facts Events 1,325 Alumni attended Health Care Initiative events in 2019 MBA Health Care Career Placement 2018 Biotech / Pharma Consulting Devices & Diagnostics Digital Health & Other Services Financial... View Details
- 29 May 2023
- News
Nurturing Breakthrough Ideas
As a center for creativity where innovation and entrepreneurship are intertwined, the Harvard Innovation Labs ecosystem encourages the development of novel ideas, approaches, and technologies that inspire new ventures or ways of thinking that keep companies relevant.... View Details
- Research Summary
Career Histories and the Biotechnology Industry
Professor Higgins' other major project focuses on the consequences of individuals' career experiences for firms and industries. This second research stream centers on the careers of executives in the biotechnology industry.
Professor Higgins has written... View Details
- 01 Jun 2023
- News
Cultivating Prosperity in Afghanistan
Kimberly Jung, pictured in a field of crocuses, returned to Afghanistan to understand how she and her cofounders could import saffron to the United States. Photo courtesy of Kimberly Jung During their first semester at HBS, former United States Army engineer officers... View Details
Keywords: Jennifer Gillespie
- 31 Mar 2023
- Research & Ideas
Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?
continuing to address health insurance problems piecemeal will only create further fractures. The US needs to work on fostering “universal access to innovative care in an affordable system,” they say. You Might Also Like: The FDA’s Speedy Drug Approvals Are Safe: A... View Details
- 01 Jun 2023
- News
An Engine of Innovation
Startup life can often feel like a solo sport, says Matt Segneri (MBA 2010), the Bruce and Bridgitt Evans Executive Director of the Harvard Innovation Labs: “What the three labs in our ecosystem do is to make building a venture something that happens within a truly... View Details
Keywords: Jennifer Gillespie
- Web
Recruiting Partners - Health Care
Carmot Therapeutics CCD International Cedars-Sinai Health System Celgene Corporation Cerner Corporation Cerulean Pharma Inc. Children's Healthcare of Atlanta Children's Hospital Boston Church & Dwight Co., Inc. Cigna City Health Works... View Details
- 22 Nov 2004
- Research & Ideas
Side Effects: The Case of Propecia
wives, believing such campaigns would not be cost effective. As Wosinska put the problem: "How does a pharma talk to barbers?" In the end, first-year sales beat internal estimates, thanks to pent-up demand. Propecia is now a... View Details
- Web
Rare Disease Day – Small Numbers, Big Challenges… and Big Opportunities - Blog: Health Supplement
Zuckerberg Initiative Rare as One network, which has been instrumental in accelerating a focus on research and clinical trials. While these are examples of great strides, the biggest challenges for rare diseases are receiving funding and attention from researchers and... View Details
- 12 Jun 2018
- Research & Ideas
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
not difficult for pharma firms. Companies tended to “either have projects on the shelf or projects that they are excited to go do when they get a little more buffer or get a little more cash,” Krieger says. Ask yourself a question What’s... View Details
- Fast Answer
Pharmaceuticals: Company Data and Analysis
not only information on pharma companies, but also covers drug pipelines and global trials, pharma deals, drug sales, and patents. Access is available to HBS AND HU students, staff and faculty onsite at... View Details
- 01 Dec 2019
- News
The Race Against Resistance
with the rise of antibiotic-resistant superbugs. “We are approaching a cliff,” says Anna Diaz Triola (MBA 2000), vice president of marketing at Summit Therapeutics in Cambridge, Massachusetts, which is part of a cohort of small pharma... View Details
Keywords: Lisa Scanlon Mogolov
- 01 Dec 2004
- News
Finding a Balance
pirate by global pharmas that consider Cipla’s products a direct rip-off of patented drugs. From 1999 through 2002, Cipla enjoyed an average annual growth rate of 30.3 percent from the sale of more than 400 drugs, including generic... View Details
Eric Boutin
Eric Boutin is a digital health investor, board member, and serial entrepreneur, helping early-stage startups to global pharma companies reimagine healthcare through science and technology. Eric helps founders launch, fund, and scale... View Details
Keywords: Healthcare